Published September, 2011
By Michael A. Kaliner
Publisher: Elsevier (W B Saunders Co Ltd)
Series: The Clinics: Internal Medicine
Rating:
Availability: Available

Focuses on essential topics in rhinitis. This title defines the primary clinical symptoms and their causes. It discusses a range of treatments, including the use of antihistamines, nasal corticosteroids, anticholinergics, decongestants, cromolyn, guafenesin, saline washes, capsaicin, and leukotriene antagonists.

---

Published September, 2011
By Mark von Itzstein and Mark Itzstein
Publisher: Springer (Birkhauser Verlag AG)
Series: Milestones in Drug Therapy
Rating:
Availability: Available

Following an overview of the influenza virus, the haemagglutinin, the interactions with the cell receptors and the enzymology of virus sialidase, recent results in drug design are presented.

---

Published September, 2011
By Andre Kamkin and Irina Kiseleva
Publisher: Springer
Series: Mechanosensitivity in Cells and Tissues
Rating:
Availability: Available

This book presents the latest findings in the field of investigation of molecular mechanisms of mechanical stretch and the role of cytokines in response of different tissues to it.

---

Published September, 2011
By I.W. Fong and Kenneth Alibek
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Emerging Infectious Diseases of the 21st Century
Rating:
Availability: Available

This volume provides guidance and answers to frequently asked questions in infectious diseases, thus facilitating improved patient care, prudent and cost effective management and investigation of these disorders. Uniquely, this volume directly discusses several controversies regarding infectious diseases from the 21st century.

---

Published September, 2011
By Michael G. Tovey and MG Tovey
Publisher: John Wiley & Sons Ltd (John Wiley & Sons Inc)
Rating:
Availability: Available

* Covers all the principal aspects of the detection and quantification of antibodies, including a review of the expectations of regulatory authorities, greatly facilitates a more uniform approach across industry.

---

Published August, 2011
By Rudolf Valenta and Robert L. Coffman
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Current Topics in Microbiology and Immunology
Rating:
Availability: Available

In fact, more than 25% of the population suffer from IgE-mediated allergies which therefore represent a major health burden of our society, particularly because untreated allergy often progresses to severe disabling forms of disease, such as asthma and sometimes kills sensitized people through anaphylaxis.

---

Published August, 2011
By Stephen P. Schoenberger, Peter D. Katsikis and Bali Pulendran
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Advances in Experimental Medicine and Biology
Rating:
Availability: Available

This volume presents a collection of reviews derived from work presented at the Aegean Conference: "3rd Crossroads between innate and adaptive immunity" which occurred during September 27 - October 2, 2009 at the Minoa Palace Conference Center in Chania, Crete, Greece.

---

Published August, 2011
By Cristobal Silva
Publisher: Oxford University Press (Oxford University Press Inc)
Rating:
Availability: Available

Miraculous Plagues examines the forms and conventions of colonial epidemiology in order to re-imagine New England's early literary history as a function of the narrative, legal, and theological responses to regional and generational patterns of illness in the seventeenth- and early eighteenth centuries.

---

Published August, 2011
By Nathalie Vergnolle and Michel Chignard
Publisher: Springer (Springer Basel)
Series: Progress in Inflammation Research
Rating: 0.00
Availability: Available

Proteases are everywhere from prokaryotes to eukaryotes, from virus to bacteria and in all human tissues, playing a role in many biological functions. This volume presents the advances in our knowledge of the role proteases and their inhibitors play in various diseases associated with inflammatory response.

---

Published July, 2011
By Roland Kontermann and Roland E. Kontermann
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Rating:
Availability: Available

The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago.

---